Strides Pharma Science Ltd

Premium

Healthcare

16 October, 2024

Swiss investor HBM leads funding in TPG-backed drugmaker at $1.65 bn valuation

Swiss investment firm HBM Healthcare has led a Rs 801 crore ($95 million) funding round in an Indian contract drug ......

Premium

Healthcare

10 May, 2024

Spotlight: Ascent-backed Skanray needs to defy one-trick-pony act to get new investors

Mysore-based medical device manufacturer Skanray Technologies Pvt. Ltd recorded robust growth during FY21 amid a raging pandemic but has since ......

Premium

Healthcare

25 September, 2023

TPG-backed firm to absorb Indian drugmaker's contract development biz, go public

An Indian biopharmaceutical company that counts private equity firm TPG as an investor will absorb a local drugmaker’s contract development ......

Premium

Healthcare

14 September, 2020

Strides Pharma, founder return to injectables biz seven years after Mylan deal

Strides Pharma Science Ltd and the family office of its founder have set up a new company to mark their ......

Premium

Healthcare

01 February, 2019

TPG Growth bets on Indian mid-sized bulk drugs firm

TPG Growth, the mid-market and growth equity platform of private equity firm TPG, has bet on a bulk-drugs company in ......

Premium

Healthcare

31 January, 2019

InvAscent's third fund strikes two more deals; hits final close

Healthcare private equity firm InvAscent has struck two new deals from its third fund that just marked its final close, ......